Name | syringaldehyde |
---|---|
Synonyms |
EINECS 205-167-5
Syringic Aldehyde 4-Hydroxy-3,5-dimethoxybenzaldehyde 4-Hydroxy-3,5-dimethoxybenzolcarbaldehyd Syringaldehyde 3,5-Dimethoxy-4-Hydroxybenzaldehyde Benzaldehyde, 4-hydroxy-3,5-dimethoxy- MFCD00006943 |
Description | Syringaldehyde is a polyphenolic compound belonging to the group of flavonoids and is found in different plant species like Manihot esculenta and Magnolia officinalis[1]. Syringaldehyde moderately inhibits COX-2 activity with an IC50 of 3.5 μg/mL[2]. Anti-hyperglycemic and anti-inflammatory activities[1]. |
---|---|
Related Catalog | |
Target |
COX-2:19.2 μM (IC50) |
In Vitro | Syringaldehyde inhibits COX-2 activity in a dosedependent manner with an IC50 of 3.5 μg/mL[2]. |
In Vivo | Syringaldehyde exerts anti-hyperglycemic effect in rat model of diabetes induced by streptozotocin. Apart from antioxidant capability, Syringaldehyde also has anti-inflammatory activity as it is found to have inhibitory action on cyclo-oxygenase 2 (COX-2) in mouse macrophage cell line[1]. |
Animal Admin | Rats[1] Adult male albino wistar rats (weighing 180-220 g) 12.5 mg/kg, 25 mg/kg, and 50 mg/kg; p.o.; for 21 days Adult male albino wistar rats are randomly divided into six groups (n=6), first group serves as control and receives vehicle (orally) for 21 days. Second group is given Syringaldehyde in saline orally at 50 mg/kg for 21 days. Third group receives vehicle for a period of 21 days and then ISO (100 mg/kg, s.c.) on 20th and 21 st day at an interval of 24 h. Fourth group is given Syringaldehyde for 21 days at 12.5 mg/kg, p.o. and ISO on 20th and 21 st day. Fifth group receives Syringaldehyde at concentration of 25 mg/kg, p.o. for 21 days and ISO on 20th and 21 st day. The sixth group is treated with 50 mg/kg of Syringaldehyde for 21 days and ISO on 20th and 21 st day. During the experimental procedure body weight of animals are monitored and on 22nd day, 24 h after second injection of ISO, rats sre sacrificed by cervical decapitation. Note: Body weight of animals belonging to different groups did not differed significantly but heart weight of ISO challenged animals were highly elevated (p ≤ 0.05) than control rats. However, treatment of rats with Syringaldehyde significantly reduced heart weight in dose dependent way. The rats treated with Syringaldehyde alone displayed an insignificant difference from control group. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 322.1±37.0 °C at 760 mmHg |
Melting Point | 110-113 °C(lit.) |
Molecular Formula | C9H10O4 |
Molecular Weight | 182.173 |
Flash Point | 130.1±20.0 °C |
Exact Mass | 182.057907 |
PSA | 55.76000 |
LogP | 0.86 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.568 |
Water Solubility | very sparingly soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S37/39 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | CU5760000 |
Packaging Group | I; II; III |
HS Code | 29124900 |
Precursor 9 | |
---|---|
DownStream 9 | |
HS Code | 2912499000 |
---|---|
Summary | 2912499000. other aldehyde-ethers, aldehyde-phenols and aldehydes with other oxygen function. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:5.5%. General tariff:30.0% |